IP Library Granted Patent US 9,140,706
Granted Patent B2
US 9,140,706 · App. 13/972,081 · Granted Sep 22, 2015

Labeling reagents and methods of their use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,140,706
App. No.
13/972,081
Granted
Sep 22, 2015
Kind
B2
Abstract

The present disclosure is directed to a reactive ester agent capable of conjugating a reporter molecule to a carrier molecule or solid support. The reactive ester agent has the general formula: wherein the variables are described throughout the application.

Claims (29)

1. A compound of Formula IA or a tautomer or salt thereof:

wherein,

L is a linker;

R 1 is a halogen;

R 2 is a halogen;

R 3 is —COO − , —SO 3 − , substituted azenyl, PEG, phosphate, or bisphosphonate; and

R a is a reporter molecule.

2. The compound of claim 1 , wherein L is a covalent bond, -alkyl-, -substituted alkyl-, -alkenyl-, -substituted alkenyl-, -heterocyclyl-, -substituted heterocyclyl-, -aryl-, -substituted aryl-, -heteroaryl-, -substituted heteroaryl-, -cycloalkyl-, -substituted cycloalkyl-, -oxy-, -alkoxy-, -substituted alkoxy-, -thio-, -amino-, or -substituted amino-.

3. The compound of claim 1 , wherein R 1 and R 2 are chloro.

4. The compound of claim 1 , wherein R 3 is —SO 3 − .

5. The compound of claim 1 , wherein R a is a dye.

6. The compound of claim 5 , wherein the dye is a xanthene, a cyanine, an indole, a benzofuran, a coumarin, or a borapolyazaindacine.

7. The compound of claim 1 , wherein R a is a chelating moiety, a hapten, an antibody, an enzyme, a radiolabel, a metal ion or metal ion containing substance, a pigment, a chromogen, a phosphor, a fluorogen, a bioluminescent substance, a chemiluminescent substance, or a semiconductor nanocrystal.

8. The compound of claim 1 , wherein the compound of Formula IA is a salt.

9. The compound of claim 8 , wherein the salt comprises a potassium or sodium ion.

10. The compound of claim 1 , wherein R a is:

or a tautomer or salt thereof;

wherein,

R 4 , R 5 , R 6 , R 7 , and R 8 are each independently selected from the group consisting of H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, acyl, acylamino, acyloxy, amino, substituted amino, aminocarbonyl, aminothiocarbonyl, aminocarbonylamino, aminothiocarbonylamino, aminocarbonyloxy, aminosulfonyl, aminosulfonyloxy, aminosulfonylamino, amidino, carboxyl, carboxyl ester, (carboxyl ester)amino, (carboxyl ester)oxy, cyano, halo, hydroxy, nitro, SO 3 − , sulfonyl, substituted sulfonyl, sulfonyloxy, thioacyl, thiol, alkylthio, substituted alkylthio, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl; or one or both of R 4 and R 7 and R 5 and R 6 are taken together to form a fused aryl or heteroaryl group; and

one of R 4 , R 5 , R 6 , R 7 , and R 8 is the point of attachment to L through a covalent bond, -alkyl-, -substituted alkyl-, -alkenyl-, -substituted alkenyl-, -heterocyclyl-, -substituted heterocyclyl-, -aryl-, -substituted aryl-, -heteroaryl-, -substituted heteroaryl-, -cycloalkyl-, -substituted cycloalkyl-, -oxy-, -alkoxy-, -substituted alkoxy-, -thio-, -amino-, or -substituted amino-.

11. A compound of Formula II or a tautomer or salt thereof:

wherein,

L is a linker;

R 1 is a halogen;

R 2 is a halogen;

R 3 is a water solubilizing group;

R 6 , R 7 and R 9 are each independently selected from the group consisting of H, alkyl, substituted alkyl, alkoxy, substituted alkoxy, acyl, acylamino, acyloxy, amino, substituted amino, aminocarbonyl, aminothiocarbonyl, aminocarbonylamino, aminothiocarbonylamino, aminocarbonyloxy, aminosulfonyl, aminosulfonyloxy, aminosulfonylamino, amidino, carboxyl, carboxyl ester, (carboxyl ester)amino, (carboxyl ester)oxy, cyano, halo, hydroxy, nitro, SO 3 − , sulfonyl, substituted sulfonyl, sulfonyloxy, thioacyl, thiol, alkylthio, substituted alkylthio, aryl, substituted aryl, heteroaryl, substituted heteroaryl, cycloalkyl, substituted cycloalkyl, heterocyclyl, and substituted heterocyclyl; and

n is 0, 1, or 2.

12. A compound selected from the group consisting of:

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 4, 2015
From: GEE, KYLE; RUKAVISHNIKOV, ALEKSEY; WITCZAK, DIANE M
To: INVITROGEN CORPORATION
Reel/Frame 036499/0035 →
MERGER Recorded Sep 4, 2015
From: INVITROGEN CORPORATION
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 036499/0088 →